Cocrystal Pharma (COCP) Operating Margin (2010 - 2026)

Cocrystal Pharma (COCP) reported Operating Margin of 1047.11% for Q1 2026, down 264.27% sequentially from 287.45% in Q4 2020.

Cocrystal Pharma (COCP) Operating Margin (2010 - 2026) Analysis & Trends

Cocrystal Pharma (COCP) has 8 years of Operating Margin data on file, last reported at 1047.11% in Q1 2026.

  • For the quarter ending Q1 2026, Operating Margin changed N/A year-over-year to 1047.11%; the trailing twelve-month figure through Mar 2026 stood at 508.1% (changed N/A YoY), and the FY2020 full-year result was 475.97%, up 26148.0% from the prior year.
  • Operating Margin declined to 1047.11% in Q1 2026, from 287.45% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 1047.11% in Q1 2026 to a low of 1047.11% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 16.51%
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 17.83%
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Cocrystal Pharma 12.57 Mn 7.74 Mn - -1,047.11%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,047.11%
Dec 31, 2020 -287.45%
Sep 30, 2020 -553.99%
Jun 30, 2020 -622.74%
Mar 31, 2020 -425.38%
Dec 31, 2019 -11,921.64%
Sep 30, 2019 -367.48%
Jun 30, 2019 -261.82%
Mar 31, 2019 56.66%
Sep 30, 2015 -14,958.33%
Jun 30, 2015 -14,137.04%
Mar 31, 2015 -8,029.63%
Jun 30, 2013 -37.85%
Mar 31, 2013 -50.27%
Dec 31, 2012 -64.08%
Sep 30, 2012 6.92%
Jun 30, 2012 5.35%
Mar 31, 2012 -16.85%
Dec 31, 2011 -21.30%
Sep 30, 2011 -56.39%